IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

56 hedge funds and large institutions have $39.9M invested in Insight Molecular Diagnostics Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 9 closing their positions.

Holders
56
Holders Change
+2
Holders Change %
+3.7%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
18
Reduced
16
Closed
9
Calls
–
Puts
$7K
Net Calls
-$7K
Net Calls Change
-$23K

Top Buyers

1
BC
1
Broadwood Capital
New York
$23.3M
2
Northern Trust
2
Northern Trust
Illinois
$524K
3
MFIM
3
Mesirow Financial Investment Management
Illinois
$353K
4
BCM
4
Bridgeway Capital Management
Texas
$568K
5
DAM
5
Doheny Asset Management
California
$295K

Top Sellers

1
MS
1
Maven Securities
Jersey
$0
2
SSA
2
Schonfeld Strategic Advisors
New York
$0
3
MHP
3
Manatuck Hill Partners
Connecticut
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.74M
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
$2K -$10K -266 -83%
TRCT
52
Tower Research Capital (TRC)
New York
$2K +$1.77K +38 +760%
MAM
53
Meeder Asset Management
Ohio
$2K +$2K +47 New
Carson Wealth (CWM LLC)
54
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
MS
55
Maven Securities
Jersey
– -$550K -10,776 Closed
SSA
56
Schonfeld Strategic Advisors
New York
– -$474K -9,525 Closed
MHP
57
Manatuck Hill Partners
Connecticut
– -$472K -9,480 Closed
Jane Street
58
Jane Street
New York
– -$178K -3,567 Closed
AG
59
Algert Global
California
– -$90K -1,808 Closed
FAM
60
Fred Alger Management
New York
– -$50K -1,000 Closed
Citadel Advisors
61
Citadel Advisors
Florida
– -$38K -757 Closed
OAM
62
Oxford Asset Management
United Kingdom
– -$33K -665 Closed
1 2
3